跳至主要内容
临床试验/NCT01137058
NCT01137058已完成不适用

Clinical Efficacy of Ubiquitous Healthcare System for Elderly Patients With Type 2 Diabetes Mellitus

Seoul National University Bundang Hospital1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2009年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
150
试验地点
1
主要终点
Target goal of HbA1c (< 7.0%) without hypoglycemia

研究概览

简要总结

Ubiquitous healthcare service for elderly patients with type 2 diabetes provides real-time glycemic monitoring and glucose control implemented by clinical decision support system (CDSS) using wire and wireless communication and information technology.

To evaluate the clinical efficacy of this system, researchers plan to compare the improvement of glycemic control, self-management, and quality of life among three study groups: control, self glucose monitoring, and U-healthcare group.

详细描述

Recently, the application of internet-based glucose control system showed better long term glucose control compared to the conventional treatment. This study has become the foundation of web-based methodology in the glucose control. In addition, the combined application of mobile device and web-based monitoring system for chronic diseases showed improvement in various metabolic parameters in obese patients with diabetes and hypertension.

Thus, the application of U-healthcare based on advanced information technology would be helpful in the diabetes management. We plan to provide an individualized U-healthcare service using advanced information technology that enables more effective glucose control.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
60 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Type 2 diabetes
  • age: 60 ~ 85 yrs
  • HbA1c: 6.5%-11.0%
  • duration of diabetes: less than 30 years
  • BMI: 20-35

排除标准

  • systemic corticosteroid administered within previous 6 months
  • history of myocardial ischemia
  • Heart failure, NYHA Class II-IV
  • Thyroid disease with abnormal TFT
  • Anti-obesity drugs or slimming products within previous 3 months

结局指标

主要结局

Target goal of HbA1c (< 7.0%) without hypoglycemia

时间窗: 24 weeks

Percent of patients who reach target goal of HbA1c (\< 7.0%) without hypoglycemia

次要结局

  • quality of life(24 weeks)
  • amount of exercise(24 weeks)
  • Body mass index (BMI) changes(Body mass index)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Soo Lim

Professor

Seoul National University Bundang Hospital

研究点 (1)

Loading locations...

相似试验